Literature DB >> 7306236

DNA in synovial fluid and the circulation of patients with arthritis.

S A Leon, M Revach, G E Ehrlich, R Adler, V Petersen, B Shapiro.   

Abstract

DNA levels were measured in synovial fluids and sera of 106 patients with rheumatoid arthritis (RA), osteoarthritis (OA), gout, pseudogout, and posttraumatic arthritis (TRA). In synovial fluids, the highest concentration was found in rheumatoid arthritis (mean +/- SE 18 +/- 3 microgram/ml for seropositive and 9 +/- 1 microgram/ml for seronegative variants), gout and pseudogout (17 +/- 3 microgram/ml). In contrast, the levels in patients with OA or acute TRA were very low: 0.8 +/- 0.1 microgram/ml an 1.1 +/- 0.2 microgram/ml, respectively. The differences between the means of the first disease group and OA or TRA is statistically significant. A similar pattern was observed for DNA levels in the circulation: in rheumatoid arthritis, the mean concentration was 135 +/- 28 ng/ml and 164 +/- 39 ng/ml for seropositive and seronegative RA, respectively. Again the levels in OA and TRA were much lower, 52 +/- 18 ng/ml and 0 ng/Ml, respectively. The latter are not significantly different from the mean levels of 95 normal, healthy controls (14 +/- 3 ng/ml), whereas the concentration of DNA in the serum of RA patients is significantly higher than in OA, TRA, or normal controls. Serial determinations of DNA and other criteria of disease activity (leukocytes and protein levels in synovial fluid, blood sedimentation rate) in individual patients revealed a strong correlation of elevated values with active episodes. THe results suggest that these parameters reflect tissue damage.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7306236     DOI: 10.1002/art.1780240905

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  12 in total

1.  A prospective study of circulating mutant KRAS2 in the serum of patients with colorectal neoplasia: strong prognostic indicator in postoperative follow up.

Authors:  B M Ryan; F Lefort; R McManus; J Daly; P W N Keeling; D G Weir; D Kelleher
Journal:  Gut       Date:  2003-01       Impact factor: 23.059

2.  Circulating Tumor Nucleic Acids: Perspective in Breast Cancer.

Authors:  Ida Casciano; Angela Di Vinci; Barbara Banelli; Claudio Brigati; Alessandra Forlani; Giorgio Allemanni; Massimo Romani
Journal:  Breast Care (Basel)       Date:  2010-04-23       Impact factor: 2.860

3.  NETosis in Psoriatic Arthritis: Serum MPO-DNA Complex Level Correlates With Its Disease Activity.

Authors:  Borui Li; Guangtao Li; Xinlei Yang; Zhibo Song; Yu Wang; Zhuoli Zhang
Journal:  Front Immunol       Date:  2022-06-14       Impact factor: 8.786

4.  Identification in synovial fluid of a new potential pathogenic player in arthropathies.

Authors:  Anna Scanu; Mariagrazia Lorenzin; Roberto Luisetto; Paola Galozzi; Augusta Ortolan; Francesca Oliviero; Andrea Doria; Roberta Ramonda
Journal:  Exp Biol Med (Maywood)       Date:  2022-04-26

5.  Extracellular plasma RNA from colon cancer patients is confined in a vesicle-like structure and is mRNA-enriched.

Authors:  José Miguel García; Vanesa García; Cristina Peña; Gemma Domínguez; Javier Silva; Raquel Diaz; Pablo Espinosa; Maria Jesús Citores; Manuel Collado; Félix Bonilla
Journal:  RNA       Date:  2008-05-02       Impact factor: 4.942

6.  DNA methylation in circulating tumour DNA as a biomarker for cancer.

Authors:  Ruth E Board; Lucy Knight; Alastair Greystoke; Fiona H Blackhall; Andrew Hughes; Caroline Dive; Malcolm Ranson
Journal:  Biomark Insights       Date:  2008-01-25

Review 7.  Breast cancer circulating biomarkers: advantages, drawbacks, and new insights.

Authors:  Andrea Ravelli; James M Reuben; Francesco Lanza; Simone Anfossi; Maria Rosa Cappelletti; Laura Zanotti; Angela Gobbi; Chiara Senti; Paola Brambilla; Manuela Milani; Daniele Spada; Paolo Pedrazzoli; Massimo Martino; Alberto Bottini; Daniele Generali
Journal:  Tumour Biol       Date:  2015-08-26

8.  Detection of HER2 amplification in circulating free DNA in patients with breast cancer.

Authors:  K Page; N Hava; B Ward; J Brown; D S Guttery; C Ruangpratheep; K Blighe; A Sharma; R A Walker; R C Coombes; J A Shaw
Journal:  Br J Cancer       Date:  2011-03-22       Impact factor: 7.640

9.  High-resolution characterization of sequence signatures due to non-random cleavage of cell-free DNA.

Authors:  Dineika Chandrananda; Natalie P Thorne; Melanie Bahlo
Journal:  BMC Med Genomics       Date:  2015-06-17       Impact factor: 3.063

Review 10.  Free DNA--new potential analyte in clinical laboratory diagnostics?

Authors:  Jasenka Wagner
Journal:  Biochem Med (Zagreb)       Date:  2012       Impact factor: 2.313

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.